Helping the kids of today become the adults of tomorrow
Fennec Pharmaceuticals is a late-stage biotechnology company dedicated to improving the lives of children with cancer who experience hearing loss as a result of chemotherapy.
Latest News
- Fennec Pharmaceuticals Receives Complete Response Letter from the FDA for its New Drug Application for PEDMARK™ to Prevent Ototoxicity Associated with Cisplatin in Pediatric Patients with Localized, Non-Metastatic, Solid Tumors
- Fennec Pharmaceuticals Expects to Receive Complete Response Letter from the FDA for its New Drug Application for PEDMARK™ to Prevent Ototoxicity Associated with Cisplatin in Pediatric Patients with Localized, Non-Metastatic, Solid Tumors
- FENNEC PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2021 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE